Back to News
Market Impact: 0.6

Wells Fargo Analyst Upgrades Evaluation of NVIDIA Corporation (NVDA)

NVDAWFC
Artificial IntelligenceSanctions & Export ControlsTrade Policy & Supply ChainTax & TariffsTechnology & InnovationAnalyst InsightsCompany FundamentalsInvestor Sentiment & Positioning
Wells Fargo Analyst Upgrades Evaluation of NVIDIA Corporation (NVDA)

Wells Fargo analyst Aaron Rakers upgraded NVIDIA after the Trump administration finalized plans to lift U.S. export restrictions on the company's H200 AI chips to China, calling the development an “incremental positive” that could add about $25–30 billion of annual revenue and boost EPS by $0.60–0.70; Wells Fargo maintained an Overweight rating with a $265 price target. However, the Financial Times reported Beijing is expected to restrict access to H200 processors despite the U.S. export license and the administration said authorized shipments would face a 25% tax, a dynamic that could blunt the commercial upside; the report trimmed NVDA premarket gains from roughly 2% to 0.6%, with shares up about 32.9% year-to-date as of Dec. 10.

Analysis

On December 9, 2025, Wells Fargo analyst Aaron Rakers upgraded NVIDIA after the Trump administration finalized plans to lift U.S. export restrictions on the company’s H200 AI chips to China, calling the move an “incremental positive” that could add roughly $25–30 billion of annual revenue and boost EPS by $0.60–0.70; Wells Fargo maintained an Overweight rating with a $265 price target. The upside thesis from the H200 is explicit in the analyst math and is reflected in the firm’s continued constructive stance. The Financial Times, citing sources, reported that Beijing regulators are expected to restrict access to H200 processors despite the U.S. export license, and the administration said authorized shipments would face a 25% tariff. Market reaction was muted: premarket gains that reached ~2% were pared to 0.6%, and NVDA shares were up 32.88% YTD as of December 10, highlighting investor sensitivity to policy nuance. The net implication is a conditional positive: U.S. licensing creates a pathway for meaningful incremental revenue, but Chinese access limits and the 25% tariff materially increase execution and margin uncertainty. Investors should treat near-term re-rating as contingent on clear, quantifiable evidence of shipments and Chinese regulatory terms rather than the licensing announcement alone.

AllMind AI Terminal